Project CBD

JUNE 20, 2023

Food and Drug Administration, three are prescribed for the treatment of chemotherapy-induced nausea and vomiting. As of March 2022, approximately 120,000 patients were registered in the program. But the most telling findings involve these patients’ perceptions of cannabis use as a treatment for IBD. 239,5 (2022): 1509-1519.

Cannabinoids 215

Cannabinoids Patients Treatment Conditions 215

Cannabis Law Report

AUGUST 23, 2021

Phase II clinical trial of the Satipharm CBD capsules showed significantly reduced monthly seizure frequency in the treatment of children suffering from refractory, or treatment-resistant epilepsy when the Satipharm capsules were added to current medications. following 12 weeks of treatment.

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

Veriheal

SEPTEMBER 1, 2022

We are honored to present the five recipients of Veriheal’s 2022 Innovation in Cannabis Scholarship. Innovation: The cannabis plant’s naturality is one of its biggest draws as a medical treatment, but cultivating it isn’t always great for the environment due to factors like heavy fertilizer use and high water consumption.

Education 105

Education Programs Cannabinoids Dispensary 105

The Blunt Truth

FEBRUARY 24, 2022

The legislation would expunge misdemeanor convictions and fund substance abuse treatment programs. So you’ll be all set for the District’s marijuana tax holiday, which runs from April 15 – 24, 2022. Democrats introduced bills in the House and Senate that would legalize adult-use marijuana in the state. supreme court.

Decriminalization 111

Decriminalization Hemp Data Agriculture 111

CannaMD

MAY 21, 2022

Finding the best treatment for autism has been a lifelong journey for many parents and caretakers. There is currently no known cure for autism, but with medical cannabis, there is hope for safe and effective treatment for autism symptoms.

Treatment 98

Treatment Cannabis Conditions 98

Medical Marijuana Program Connection

JANUARY 26, 2023

IIP) (NYSE: IIPR) today announced the tax treatment of its 2022 distributions as follows: Read More SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc.

Treatment 52

Treatment Business 52

SpeedWeed

SEPTEMBER 13, 2021

That news comes via AL.com , which said that the Alabama Medical Cannabis Commission has been in discussions with state legislators “about changing the date to allow cultivators to be licensed sooner, by no later than early 2022.”. Furthermore, we reject the notion that cannabis should be a treatment of ‘last resort.’

Cultivation 90

Cultivation Marijuana Treatment Legislation 90

Project CBD

FEBRUARY 27, 2023

In the absence of an answer — or a cure — treatment is the name of the game for fibromyalgia. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.”

THC 144

THC CBD Clinical Trials Sleep 144

TheAnswerPage

JULY 1, 2022

On June 21, 2022, Purdue Pharma announced that Nalmefene HCl Injection, 2mg/2mL (1mg/1mL) is now available in the U.S. for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. June 21, 2022. For what condition is Nalmefene HCl indicated? See the Answer.

Treatment 75

Treatment Conditions Cannabis 75

Project CBD

FEBRUARY 1, 2023

Cannabinoid-infused topicals show particular promise in the treatment of psoriasis, atopic dermatitis, and contact dermatitis. Next, the study authors review existing clinical and preclinical evidence on the effects of cannabinoid treatment for a long list of skin diseases both common and obscure. Suffice to say, they are thorough.

Conditions 130

Conditions THC CBD Cannabinoids 130

The Cannigma

JULY 12, 2022

Roll out of the program has been slow, and as of June 2022, there were still no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products. Unlike other states, Alabama requires doctors to document a failure of conventional medical treatment before issuing a medical cannabis prescription.

Legalization 142

Legalization Chronic Pain Programs Treatment 142

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: [link] Accessed October 17, 2022. February 2, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 10, 2022

All this bill does is create a framework for the state to expand potential treatments for mental health,” Grieco told Florida Politics. People don’t realize they’ve been studying these substances for mental health treatment going back to the ’50s. It wasn’t crazy then, and it isn’t crazy now.”. Source: [link].

Therapy 97

Therapy Treatment Legislation Law 97

TheAnswerPage

MAY 22, 2022

According to this document, are there any blood tests that should be performed prior to initiating treatment with Epidiolex? Yes, it is suggested that serum transaminases (ALT and AST) and total bilirubin levels be obtained prior to starting treatment with Epidiolex.

Treatment 75

Treatment Patients CBD 75

Cannabis Law Report

JANUARY 31, 2022

IIP) (NYSE: IIPR) today announced an amendment to its initial tax treatment of its 2021 distributions that was provided in a press release dated January 28, 2022. The amended tax treatment of its 2021 distributions is as follows: Security Description: Common Stock. 01/14/2022. 01/14/2022. CUSIP: 45781V101.

Treatment 52

Treatment Business Cannabis 52

Cannabis Law Report

JANUARY 28, 2022

IIP) (NYSE: IIPR) today announced the tax treatment of its 2021 distributions as follows: Security Description: Common Stock. 01/14/2022. 01/14/2022. allocable to 2022 for federal income tax purposes. SAN DIEGO–(BUSINESS WIRE)– $IIPR #Dividendstocks –Innovative Industrial Properties, Inc. Record Date.

Treatment 52

Treatment Business Cannabis 52

Medical Marijuana Program Connection

JANUARY 19, 2023

DUBLIN–(BUSINESS WIRE)–The “Substance Abuse Treatment Market Research Report by Substance Abuse Type (Alcohol Addiction, Cocaine, and Marijuana), Product, Treatment Option, Read More

Treatment 52

Treatment Business Marijuana 52

MMJ Recs

MARCH 10, 2022

Getting a Pennsylvania medical marijuana card 2022 is a straightforward process. The process of applying for your Pennsylvania MMJ card in 2022 is easy to navigate and can be done entirely online. Read on as we outline the steps involved and discuss how you can use your PA MMJ card in 2022!

Dispensary 52

Dispensary Conditions Treatment Epilepsy 52

Cannabis Law Report

NOVEMBER 30, 2022

INDUSTRY NEWS NOVEMBER 2022 CANNABIS Cannabinoids Alabama forbids CBD in food: [link] CBD as a treatment and protectant for Traumatic Brain Injury: [link] UK bans 100 CBD products including Charlotte’s Web: [link] Coors exits CBD drink joint venture with HEXO due to “no near-term pathway to federal legalization:” [link] Newsweek on studies (..)

Cannabinoids 52

Cannabinoids Food Treatment CBD 52

MMJ Recs

JANUARY 25, 2022

So now that medical marijuana is finally available in Ohio, how do you get an Ohio MMJ card in 2022? Not all doctors in Ohio are certified to recommend medical marijuana treatment. How Do I Get My Ohio MMJ Card In 2022? What Are The Qualifying Conditions For A Medical Card In Ohio In 2022? Read on to find out!

Dispensary 52

Dispensary Chronic Pain Programs Treatment 52

MMJ Recs

MARCH 15, 2022

If you’ve decided that this is the year that you’d like to try MMJ treatment, read on for our guide on how to get your Missouri MMJ card in 2022 – and all the benefits it can bring you. Image by CBD-Infos-com on Pixabay : How do I get my Missouri MMJ card in 2022? The post How Do I Get My Missouri MMJ Card In 2022?

Conditions 52

Conditions Treatment Epilepsy Dispensary 52

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis. .

Therapy 52

Therapy Treatment Clinical Trials Access 52

MMJ Recs

FEBRUARY 4, 2022

If you’ve decided that this is the year you want to start using MMJ to alleviate your symptoms, read on for more information on how to get your Oklahoma MMJ card in 2022. Residents of the state of Oklahoma qualify for an OK MMJ card provided that they have a medical condition that a licensed state physician deems suitable for MMJ treatment.

Conditions 52

Conditions Treatment Edibles Patients 52

Cannabis Law Report

AUGUST 23, 2021

A 10% tax on marijuana sales would go to funding jobs, addiction treatment and community support for areas with marijuana businesses. The attorney general’s approval is the first step in a long process that could end with the November 2022 election. The proposal would change state law but not the state constitution.

Law 105

Law Legalization Treatment State Laws 105

Project CBD

DECEMBER 31, 2022

In recent years, psilocybin and MDMA have been explored as potential treatments for post-traumatic stress disorder, but somewhat more quietly so has cannabis. Yet a paucity of clinical evidence limits its use, write the London-based authors of a December 2022 paper in the journal Expert Review of Neurotherapeutics.

Sleep 130

Sleep Patients Treatment Cannabis 130

The Cannigma

JULY 5, 2022

But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. Despite having 20,000 registered patients in March of 2022, there are no licensed producers or distributors of cannabis products and sales are unlikely to start before mid-2023 at the earliest.

Law 119

Law Decriminalization Programs Patients 119

Cannabis Law Report

SEPTEMBER 15, 2022

A new law passed in July 2022 eliminates the state’s weight-based cannabis cultivation tax to be paid by market growers and created new tax credits for certain cannabis businesses. In 2022, the D.C. Because there was no regular session for the state legislature in 2022, no new state laws related to cannabis were introduced or passed.

Recreational 52

Recreational Legislation Research and Development Retail 52

Cannabis Law Report

AUGUST 13, 2021

Derived from Salvia divinorum, SalA is a unique non-nitrogenous agonist of the kappa-opioid receptor (KOR) with potential use in treatment-resistant depression (TRD), substance use disorder (SUD) and pain. Clinically, there are published reports of the potential benefits of Salvia divinorum in the treatment of TRD. BERLIN, Aug.

Conditions 105

Conditions Research and Development Clinical Trials Treatment 105

Leafly

NOVEMBER 10, 2022

Psilocybin treatment centers will likely open in 2025. The measure decriminalizes psychedelic possession almost immediately. The post Colorado just voted to legalize and decriminalize psychedelics. Here’s what happens next appeared first on Leafly.

Decriminalization 137

Decriminalization Legalization Treatment 137

Cannabis Law Report

FEBRUARY 9, 2022

Cybin plans to submit a clinical trial application for a pilot study of CYB004 in the second quarter of calendar year 2022 and expects to initiate the pilot study in the third quarter of calendar year 2022.

Treatment 52

Treatment Clinical Trials Research and Development 52

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Connecticut Gov. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Leafwell

JANUARY 11, 2022

Only about 37 percent of people afflicted with anxiety receive treatment. According to the Anxiety and Depression Association of America (ADAA), 40 million U.S. adults grapple with anxiety disorders each year. Anxiety disorders are America’s most common mental illness and are deemed highly treatable. The 63 percent of anxiety-plagued.

CBD 63

CBD Treatment Conditions Cannabis 63

Veriheal

SEPTEMBER 7, 2022

On July 6, 2022, Washington, D.C. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C. law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. implemented a revolutionary emergency amendment to its medical cannabis program.

Patients 98

Patients Programs Access Treatment 98

Cannabis Law Report

NOVEMBER 17, 2021

There is one problem, Malaysia currently has no registered cannabis-based treatment. In a press event, public health minister, Anutin Charnvirakul said that the ministry would promote medical cannabis to help people access treatment safely and within the law. Importers would be required to hold permits and licenses.

Research and Development 111

Research and Development Patients Treatment Pharmaceutical 111

TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Their findings included the following: “The average daily dose ranged between 1 and 50 mg/kg, with treatment length from 3 to 12 months (mean 6.2 12 September 2018.

Epilepsy 56

Epilepsy Extraction Treatment CBD 56

Veriheal

MAY 16, 2022

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Cannabis Law Report

MAY 18, 2022

Wednesday 18 May 2022. It will consider the potential harms and benefits of controlled drugs, and the treatments available for drug addiction and whether they are adequate. The Committee takes evidence from members of the Advisory Council on the Misuse of Drugs, which advises the Government on drugs policy, and other academic experts.

Policy 52

Policy Treatment Legislation Access 52